Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands · Delayed Price · Currency is EUR 1.120
-0.005 (-0.44%)
Aug 14, 2026, 5:35 PM CET
Vivoryon Therapeutics Market Cap
Vivoryon Therapeutics has a market cap or net worth of €33.17 million as of August 14, 2026. Its market cap has decreased by -10.96% in one year.
Market Cap
33.17M
Enterprise Value
30.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.12
ChartMarket Cap Chart
Since October 27, 2014, Vivoryon Therapeutics's market cap has decreased from 135.32M to 33.17M, a decrease of -75.49%. That is a compound annual growth rate of -11.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 33.17M | -21.13% |
| Dec 31, 2025 | 42.05M | -18.93% |
| Dec 31, 2024 | 51.87M | -75.55% |
| Dec 29, 2023 | 212.18M | -14.71% |
| Dec 30, 2022 | 248.77M | -34.70% |
| Dec 31, 2021 | 380.96M | 111.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Morefield Group | 59.52M |
| BM3EAC | 53.98M |
| Bever Holding NV | 49.47M |
| Cabka | 48.43M |
| Ebusco Holding | 48.27M |
| New Amsterdam Invest | 44.55M |
| Ctac N.V. | 39.90M |
| Arcona Property Fund | 25.36M |